Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-25

Clinical Trial Update: A Comparison Between Palonosetron Versus Granisetron as PONV Prophylaxis in Scoliotic Patients Undergoing Spine Surgery [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing palonosetron and granisetron for prevention of postoperative nausea and vomiting in scoliosis surgery, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Granisetron (granisetron)
  • Palonosetron (palonosetron)

Snippet

Sponsor: University of Malaya | Conditions: Postoperative Nausea and Vomiting, Scoliosis | Phase 4 | Status: RECRUITING